![Christopher Murray](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Murray
No más puestos en curso
Perfil
Christopher K.
Murray worked at ARIAD Pharmaceuticals, Inc. from 2004 to 2017, serving as Vice President-Technical Operations from 2013 to 2017.
Dr. Murray worked at Blueprint Medicines Corp.
from 2017 to 2025, serving as Chief Technical Operations & Quality Officer.
Dr. Murray completed undergraduate studies at Hope College in 1984 and graduate studies at The University of Chicago in 1990.
Últimas noticias acerca de Christopher Murray
Antiguos cargos conocidos de Christopher Murray.
| Empresas | Cargo | Fin |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Director Técnico/Científico/I+D | 01/04/2025 |
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2017 |
Formación de Christopher Murray.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
79
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Hope College
 Hope College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
- Bolsa de valores
- Insiders
- Christopher Murray
